Methods of treating muscular dystrophies

2) A method of treating muscular dystrophies, comprising:

• a) providing a pharmaceutical composition comprising a therapeutically effective amount of flavonoid;
• and
• b) administering the composition to a human patient;
• wherein the flavonoid comprises a flavan-3-ol nucleus, and wherein at least one of the carbons of the nucleus located at positions 8, 7, 6, 5, 4, 2′, 3′, 4′, 5′, or 6′ is modified by an alcohol group.

3) A method of treating Duchenne muscular dystrophy, comprising:

• a) providing a pharmaceutical composition comprising a therapeutically effective amount of flavonoid;
• and
• b) administering the composition to a human patient;
• wherein the flavonoid comprises a Free-B-Ring flavone nucleus, wherein at least one of the carbons of the nucleus located at positions 8, 7, 6, 5 or 3 is modified by an alcohol group, and wherein at least one of the carbons of the nucleus located at positions 8, 7, 6, 5 or 3 is modified by a glycoside group.